Evaluation of antibacterial efficacy of sulfur nanoparticles alone and in combination with antibiotics against multidrug-resistant uropathogenic bacteria

References

• Flores-Mireles, A. L.; Walker, J. N.; Caparon, M.; Hultgren, S. J. Urinary Tract Infections: Epidemiology, Mechanisms of Infection and Treatment Options. Nat. Rev. Micro. 2015, 13, 269–284. doi: 10.1038/nrmicro3432.
   PubMed Web of Science ®Google Scholar
• Armbruster, C. E.; Smith, S. N.; Johnson, A. O.; DeOrnellas, V.; Eaton, K. A.; Yep, A.; Mody, L.; Wu, W.; Mobley, H. L. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection. Infect. Immun. 2017, 85, 00808–008016.
   Web of Science ®Google Scholar
• Wagenlehner, F. M.; Naber, K. G. A New Way to Prevent Urinary Tract Infections? Lancet Infect. Dis. 2017, 17, 467–468. doi: 10.1016/S1473-3099(17)30107-X.
   PubMed Web of Science ®Google Scholar
• Mody, L.; Juthani-Mehta, M. Urinary Tract Infections in Older Women: A Clinical Review. JAMA. 2014, 311, 844–854.
   PubMed Web of Science ®Google Scholar
• Fatima, S. S.; Mussaed, E. A. Urinary tract infection. In Bacterial Identification and Drug Susceptibility Patterns in Pregnant and Non-Pregnant UTI Patients; Fatima, S.S.; Mussaed, E.A.; Eds.; Springer: Singapore, 2018; pp. 1–22.
   Google Scholar
• Pezzani, M. D.; Antinori, S. Introduction to urinary tract infections: An overview on epidemiology, risk factors, microbiology and treatment options. In Imaging and Intervention in Urinary Tract Infections and Urosepsis; Tonolini, M., Eds.; Springer: Cham, 2018; pp. 7–16.
   Google Scholar
• Foxman, B.; Brown, P. Epidemiology of Urinary Tract Infections: Transmission and Risk Factors, incidence, and Costs. Infect. Dis. Clin. North Am. 2003, 17, 227–241. doi: 10.1016/S0891-5520(03)00005-9.
   PubMed Web of Science ®Google Scholar
• Pushpalatha, K. S. Urinary Tract Infection and Management. J. Night Nurs. Times. 2008, 4, 28–32.
   Google Scholar
• Hotchandani, R.; Aggarwal, K. K. A Review Article on Urinary Tract Infections in Women. Indian J. Clin. Practice. 2012, 24, 187–192.
   Google Scholar
• Vasudevan, R. Urinary Tract Infection: An Overview of the Infection and the Associated Risk Factors. JMEN. 2014, 1, 1–15.
   Google Scholar
• Manikandan, S.; Ganesapand, S.; Singh, M.; Kumaraguru, A. K. Emergence of Multi-drug Resistance Human Pathogens from Urinary Tract Infection. Curr. Res. Bacteriol. 2011, 4, 9–15. doi: 10.3923/crb.2011.9.15.
   Google Scholar
• Tamalli, M.; Sangar, B.; Alghazal, M. A. Urinary Tract Infection during Pregnancy at Al-Khoms, Libya. Int. J. Med. Medical Sci. 2013, 3, 455–459.
   Google Scholar
• Venkatesh, R. K.; Prabhu, M. M.; Nandakumar, K.; Pai, K. S. R. Urinary Tract Infection Treatment Pattern of Elderly Patients in a Tertiary Hospital Setup in South India: A Prospective Study. Jyp. 2016, 8, 108–113. doi: 10.5530/jyp.2016.2.9.
   Web of Science ®Google Scholar
• Choudhury, S. R.; Goswami, A. Supramolecular Reactive Sulphur Nanoparticles: a Novel and Efficient Antimicrobial Agent. J. Appl. Microbiol. 2012, 114, 1–10. doi: 10.1111/j.1365-2672.2012.05422.x.
   PubMed Web of Science ®Google Scholar
• Rai, M.; Ingle, A. P.; Paralikar, P. Sulfur and Sulfur Nanoparticles as Potential Antimicrobials: from Traditional Medicine to Nanomedicine. Expert Rev. Anti. Infect. Ther. 2016, 14, 969–978. doi: 10.1080/14787210.2016.1221340.
   PubMed Web of Science ®Google Scholar
• Deshpande, A. S.; Khomane, B. R.; Vaidya, B. K.; Joshi, R. M.; Harle, A. S.; Kulkarni, B. D. Sulfur Nanoparticles Synthesis and Characterization from H2S Gas, using Novel Biodegradable Iron Chelates in w/o Microemulsion. Nanoscale Res. Lett. 2008, 3, 221–229. doi: 10.1007/s11671-008-9140-6.
   Web of Science ®Google Scholar
• Chaudhuri, R. G.; Paria, S. Growth Kinetics of Sulfur Nanoparticles in Aqueous Surfactant Solutions. J. Colloid Interface Sci. 2011, 354, 563–569. doi: 10.1016/j.jcis.2010.11.039.
   PubMed Web of Science ®Google Scholar
• Paralikar, P.; Rai, M. Bio-inspired Synthesis of Sulphur Nanoparticles Using Leaf Extract of Four Medicinal Plants with Special Reference to Their Antibacterial Activity. IET Nanobiotechnol. 2018, 12, 25–31. doi: 10.1049/iet-nbt.2017.0079.
   Web of Science ®Google Scholar
• Paul, S.; Kannan, I.; Jeyakumari, D.; Premavathi, R. K.; Shantha, S. Evaluation of Chromogenic Agar and Direct Antimicrobial Susceptibility Testing in Rapid Diagnosis of Acute Urinary Tract Infection. Int. J. Pharm. Clin. Res. 2015, 7, 333–336.
   Google Scholar
• Birla, S. S.; Tiwari, V. V.; Gade, A. K.; Ingle, A. P.; Yadav, A. P.; Rai, M. K. Fabrication of Silver Nanoparticles by Phoma glomerata and Its Combined Effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett. Appl. Microbiol 2009, 48, 173–179. doi: 10.1111/j.1472-765X.2008.02510.x.
   PubMed Web of Science ®Google Scholar
• Prema, P.; Iniya, P. A.; Immanuel, G. Microbial Mediated Synthesis, characterization, antibacterial and Synergistic Effect of Gold Nanoparticles Using Klebsiella pneumoniae (MTCC-4030). RSC Adv. 2016, 6, 4601–4607. doi: 10.1039/C5RA23982F.
   Web of Science ®Google Scholar
• Farajnia, S.; Alikhani, M. Y.; Ghotaslou, R.; Naghili, B.; Nakhlband, A. Causative Agents and Antimicrobial Susceptibilities of Urinary Tract Infections in the Northwest of Iran. Int. J. Infect Dis. 2009, 13, 140–144. doi: 10.1016/j.ijid.2008.04.014.
   PubMed Web of Science ®Google Scholar
• Nerurkar, A.; Solanky, P.; Naik, S. S. Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern. J. Pharm. Biomed. Sci. 2012, 21, 1–3.
   Google Scholar
• Price, T. K.; Hilt, E. E.; Dune, T. J.; Mueller, E. R.; Wolfe, A. J.; Brubaker, L. Urine Trouble: should we Think Differently about UTI? Int. Urogynecol. J. 2018, 29, 205–210. doi: 10.1007/s00192-017-3528-8.
   PubMed Web of Science ®Google Scholar
• Mittal, R.; Aggarwal, S.; Sharma, S.; Chhibber, S.; Harjai, K. Urinary Tract Infections Caused by Pseudomonas aeruginosa: A Minireview. J. Infect. Public Health. 2009, 2, 101–111. doi: 10.1016/j.jiph.2009.08.003.
   PubMedGoogle Scholar
• Bitsori, M.; Maraki, S.; Koukouraki, S.; Galanakis, E. Pseudomonas aeruginosa Urinary Tract Infection in Children: risk Factors and Outcomes. J. Urol. 2012, 187, 260–264. doi: 10.1016/j.juro.2011.09.035.
   PubMed Web of Science ®Google Scholar
• Akoachere, J.-F. T. K.; Yvonne, S.; Akum, N. H.; Seraphine, E. N. Etiologic Profile and Antimicrobial Susceptibility of Community-acquired Urinary Tract Infection in Two Cameroonian Towns. BMC Res. Notes 2012, 5, 219–227. doi: 10.1186/1756-0500-5-219.
   PubMedGoogle Scholar
• Nzalie, R. N.; Gonsu, H. K.; Koulla-Shiro, S. Bacterial Etiology and Antibiotic Resistance Profile of Community-acquired Urinary Tract Infections in a Cameroonian City. Int. J. Microbiol. 2016, 2016, 1–6. doi: 10.1155/2016/3240268.
   Google Scholar
• Kahlmeter, G.; Odén Poulsen, H. Antimicrobial Susceptibility of Escherichia coli from Community-acquired Urinary Tract Infections in Europe: The ECO·SENS Study Revisited. Int. J. Antimicrobial Agents. 2012, 39, 45–51. doi: 10.1016/j.ijantimicag.2011.09.013.
   PubMed Web of Science ®Google Scholar
• Mishra, M. P.; Sarangi, R.; Padhy, R. N. Prevalence of Multidrug Resistant Uropathogenic Bacteria in Pediatric Patients of a Tertiary Care Hospital in Eastern India. J. Infect. Public Health. 2016, 9, 308–314. doi: 10.1016/j.jiph.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Olorunmola, F. O.; Kolawole, D. O.; Lamikanra, A. Antibiotic Resistance and Virulence Properties in Escherichia coli Strains from Cases of Urinary Tract Infections. African J. Infect. Dis. 2013, 7, 1–7.
   PubMedGoogle Scholar
• Awwad, A. M.; Salem, N. M.; Abdeen, A. O. Novel Approach for Synthesis Sulfur (S-NPs) nanoparticles Using Albizia julibrissin Fruits Extract. Aml. 2015, 6, 432–435. doi: 10.5185/amlett.2015.5792.
   Google Scholar
• Suryavanshi, P.; Pandit, R.; Gade, A.; Derita, M.; Zachino, S.; Rai, M. Colletotrichum sp. mediated Synthesis of Sulphur and Aluminium Oxide Nanoparticles and Its in Vitro Activity against Selected Food-borne Pathogens. LWT – Food Sci. Technol. 2017, 81, 188–194. doi: 10.1016/j.lwt.2017.03.038.
   Web of Science ®Google Scholar
• Składanowski, M.; Wypij, M.; Laskowski, D.; Golińska, P.; Dahm, H.; Rai, M. Silver and Gold Nanoparticles Synthesized from Streptomyces sp. isolated from Acid Forest Soil with Special Reference to Its Antibacterial Activity against Pathogens. J. Clust. Sci. 2017, 28, 59–79. doi: 10.1007/s10876-016-1043-6.
   Web of Science ®Google Scholar
• Shah, R.; Eldridge, D.; Palombo, E.; Harding, I. Lipid Nanoparticles: Synthesis, Production and Stability. Springer: Cham, Heidelberg, New York, Dordrecht, London. 2015; p. 105.
   Google Scholar
• Heurtault, B.; Saulnier, P.; Pech, B.; Proust, J.-E.; Benoit, J.-P. Physico-chemical Stability of Colloidal Lipid Particles. Biomaterials. 2003, 24, 4283–4300. doi: 10.1016/S0142-9612(03)00331-4.
   PubMed Web of Science ®Google Scholar
• Wu, L.; Zhang, J.; Watanabe, W. Physical and Chemical Stability of Drug Nanoparticles. Adv. Drug Deliv. Rev. 2011, 63, 456–469.
   PubMed Web of Science ®Google Scholar
• Mitri, K.; Shegokar, R.; Gohla, S.; Anselmi, C.; Müller, R. Lipid Nanocarriers for Dermal Delivery of Lutein: Preparation, characterization, stability and Performance. Int. J. Pharm. 2011, 414, 267–275. 2011, doi: 10.1016/j.ijpharm.2011.05.008.
   PubMed Web of Science ®Google Scholar
• Tamjidi, F.; Shahedi, M.; Varshosaz, J.; Nasirpour, A. Nanostructured Lipid Carriers (NLC): a Potential Delivery System for Bioactive Food Molecules. Innov. Food Sci. Emerg. Technol. 2013, 19, 29–43. doi: 10.1016/j.ifset.2013.03.002.
   Web of Science ®Google Scholar
• Bunjes, H.; Siekmann, B. Manufacture, Characterization, and Applications of Solid Lipid Nanoparticles as Drug Delivery Systems. Microencapsulation: Methods and Industrial Applications. Drugs and the Pharmaceutical Sciences. CRC Press: New York, 2005.; 213–268.
   Google Scholar
• Choudhury, S. R.; Roy, S.; Goswami, A.; Basu, S. Polyethylene Glycol-stabilized Sulphur Nanoparticles: an Effective Antimicrobial Agent against Multidrug-resistant Bacteria. J. Antimicrob. Chemother. 2012, 67, 1134–1137. doi: 10.1093/jac/dkr591.
   PubMed Web of Science ®Google Scholar
• Rathod, D.; Golinska, P.; Wypij, M.; Dahm, H.; Rai, M. A New Report of Nocardiopsis valliformis Strain OT1 from Alkaline Lonar Crater of India and Its Use in Synthesis of Silver Nanoparticles with Special Reference to Evaluation of Antibacterial Activity and Cytotoxicity. Med. Microbiol. Immunol. 2016, 205, 435–447. doi: 10.1007/s00430-016-0462-1.
   PubMed Web of Science ®Google Scholar
• Thirumurugan, G.; Seshagiri Rao, J. V. L. N.; Dhanaraju, M. D. Elucidating Pharmacodynamics Interaction of Silver Nanoparticle Topical Deliverable Antibiotics. Scientific Rep. 2016, 6, 29982.
   PubMed Web of Science ®Google Scholar
• Wypij, M.; Czarnecka, J.; Świecimska, M.; Dahm, H.; Rai, M.; Golinska, P. Synthesis, characterization and Evaluation of Antimicrobial and Cytotoxic Activities of Biogenic Silver Nanoparticles Synthesized from Streptomyces xinghaiensis OF1 Strain. World J. Microbiol. Biotechnol. 2018, 34, 23–35.
   PubMed Web of Science ®Google Scholar
• Abreu, A. C.; McBain, A. J.; Simoes, M. Plants as Sources of New Antimicrobials and Resistance-modifying Agents. Nat. Prod. Rep. 2012, 29, 1007–1021.
   PubMed Web of Science ®Google Scholar
• Halder, S.; Yadav, K. K.; Sarkar, R.; Mukherjee, S.; Saha, P.; Halder, S.; Karmakar, S.; Sen, T. Alteration of Zeta Potential and Membrane Permeability in Bacteria: A Study with Cationic Agents. Springer Plus. 2015, 4, 672.
   PubMedGoogle Scholar
• Arakha, M.; Saleem, M.; Mallick, B. C.; Jha, S. The Effects of Interfacial Potential on Antimicrobial Propensity of ZnO Nanoparticle. Sci. Rep. 2015, 5, 1–10.
   Web of Science ®Google Scholar
• Ahmad, A.; Wei, Y.; Syed, F.; Tahir, K.; Rehman, A. U.; Khan, A.; Ullah, S.; Yuan, Q. The Effects of Bacteria-nanoparticles Interface on the Antibacterial Activity of Green Synthesized Silver Nanoparticles. Microb. Pathog. 2017, 102, 133–142.
   PubMed Web of Science ®Google Scholar